Carl Decicco, Chief Scientific Officer at Foghorn Therapeutics Inc. (FHTX), bought 5,500 shares at $16.00 ($88K) on 2020-10-27, disclosed to the SEC on 2020-10-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.